Determination of the two major endocannabinoids in human plasma by μ-SPE followed by HPLC-MS/MS
暂无分享,去创建一个
[1] D. Tsikas,et al. Simultaneous UPLC-MS/MS quantification of the endocannabinoids 2-arachidonoyl glycerol (2AG), 1-arachidonoyl glycerol (1AG), and anandamide in human plasma: minimization of matrix-effects, 2AG/1AG isomerization and degradation by toluene solvent extraction. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[2] D. Tsikas,et al. Quantification of endocannabinoids in biological systems by chromatography and mass spectrometry: a comprehensive review from an analytical and biological perspective. , 2011, Biochimica et biophysica acta.
[3] B. Gorzalka,et al. Putative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[4] P. Hyytiä,et al. Determination of endocannabinoids in nematodes and human brain tissue by liquid chromatography electrospray ionization tandem mass spectrometry. , 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[5] R. Curini,et al. Determination of Illicit Drugs in Urine and Plasma by Micro-SPE Followed by HPLC–MS/MS , 2011, Chromatographia.
[6] A. Amoako,et al. Quantitative analysis of anandamide and related acylethanolamides in human seminal plasma by ultra performance liquid chromatography tandem mass spectrometry. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[7] E. Dainese,et al. Intracellular trafficking of anandamide: new concepts for signaling. , 2010, Trends in biochemical sciences.
[8] Roberta Risoluti,et al. Micro-solid phase extraction coupled with high-performance liquid chromatography-tandem mass spectrometry for the determination of stimulants, hallucinogens, ketamine and phencyclidine in oral fluids. , 2010, Analytica chimica acta.
[9] Hao Wang,et al. Validation and application of an LC-MS/MS method for quantitation of three fatty acid ethanolamides as biomarkers for fatty acid hydrolase inhibition in human plasma. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[10] V. D. M. A. L. D. Petrocellis. Endocannabinoids as regulators of transient receptor potential (TRP) channels: A further opportunity to develop new endocannabinoid-based therapeutic drugs. , 2010 .
[11] P. Chanda,et al. Simultaneous determination of 2-arachidonoylglycerol, 1-arachidonoylglycerol and arachidonic acid in mouse brain tissue using liquid chromatography/tandem mass spectrometry. , 2010, Journal of mass spectrometry : JMS.
[12] B. Barroso,et al. Simultaneous quantitative analysis of N-acylethanolamides in clinical samples. , 2009, Analytical biochemistry.
[13] M. Maccarrone. Endocannabinoids: friends and foes of reproduction. , 2009, Progress in lipid research.
[14] M. Nagarkatti,et al. Endocannabinoids and immune regulation. , 2009, Pharmacological research.
[15] J. Ozer,et al. Endogenous ethanolamide analysis in human plasma using HPLC tandem MS with electrospray ionization. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[16] M. García,et al. Enhancement of the hypotensive effects of intrathecally injected endocannabinoids by the entourage compound palmitoylethanolamide. , 2009, European journal of pharmacology.
[17] K. Verhoeckx,et al. Development and validation of a quantitative method for the determination of 12 endocannabinoids and related compounds in human plasma using liquid chromatography-tandem mass spectrometry. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[18] Aurélien Thomas,et al. Quantitative and qualitative profiling of endocannabinoids in human plasma using a triple quadrupole linear ion trap mass spectrometer with liquid chromatography. , 2009, Rapid communications in mass spectrometry : RCM.
[19] L. Petrocellis,et al. An introduction to the endocannabinoid system: from the early to the latest concepts , 2009 .
[20] A. Taylor,et al. A solid-phase method for the extraction and measurement of anandamide from multiple human biomatrices. , 2009, Analytical biochemistry.
[21] D. Barrett,et al. ‘Entourage’ effects of N‐palmitoylethanolamide and N‐oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors , 2008, British journal of pharmacology.
[22] A. Taylor,et al. Ultra performance liquid chromatography tandem mass spectrometry method for the measurement of anandamide in human plasma. , 2008, Analytical biochemistry.
[23] J. Klosterkötter,et al. Determination of anandamide and other fatty acyl ethanolamides in human serum by electrospray tandem mass spectrometry. , 2007, Analytical biochemistry.
[24] K. Mackie,et al. The emerging functions of endocannabinoid signaling during CNS development. , 2007, Trends in pharmacological sciences.
[25] Olaf H Drummer,et al. Validation of new methods. , 2007, Forensic science international.
[26] D. Barrett,et al. Quantitative profiling of endocannabinoids and related compounds in rat brain using liquid chromatography-tandem electrospray ionization mass spectrometry. , 2007, Analytical biochemistry.
[27] G. Schelling,et al. Pitfalls in measuring the endocannabinoid 2-arachidonoyl glycerol in biological samples , 2007, Clinical chemistry and laboratory medicine.
[28] P. Pacher,et al. The Endocannabinoid System as an Emerging Target of Pharmacotherapy , 2006, Pharmacological Reviews.
[29] M. Maj,et al. Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia. , 2006, The Journal of clinical endocrinology and metabolism.
[30] M. Maj,et al. Blood Levels of the Endocannabinoid Anandamide are Increased in Anorexia Nervosa and in Binge-Eating Disorder, but not in Bulimia Nervosa , 2005, Neuropsychopharmacology.
[31] A. Giuffrida,et al. Cannabimimetic Effects of Osteopathic Manipulative Treatment , 2005, The Journal of the American Osteopathic Association.
[32] V. Marzo,et al. Endocannabinoid control of food intake and energy balance , 2005, Nature Neuroscience.
[33] Y. Tanifuji,et al. Simultaneous determination of endocannabinoids (arachidonylethanolamide and 2-arachidonylglycerol) and isoprostane (8-epiprostaglandin F2alpha) by gas chromatography-mass spectrometry-selected ion monitoring for medical samples. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[34] B. Incledon,et al. Optimization of protein precipitation based upon effectiveness of protein removal and ionization effect in liquid chromatography-tandem mass spectrometry. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[35] L. Marnett,et al. Chemical stability of 2-arachidonylglycerol under biological conditions. , 2002, Chemistry and physics of lipids.
[36] F. Bymaster,et al. Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. , 2002, The Journal of pharmacology and experimental therapeutics.
[37] Z. Vogel,et al. 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[38] M. Maccarrone,et al. Gas chromatography–mass spectrometry analysis of endogenous cannabinoids in healthy and tumoral human brain and human cells in culture , 2001, Journal of neurochemistry.
[39] L. Petrocellis,et al. N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo. , 2000, The Biochemical journal.
[40] D. Piomelli,et al. Quantification of bioactive acylethanolamides in rat plasma by electrospray mass spectrometry. , 2000, Analytical biochemistry.
[41] M. Palkovits,et al. Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat , 1996, FEBS letters.
[42] P. C. Schmid,et al. Occurrence and postmortem generation of anandamide and other long‐chain N‐acylethanolamines in mammalian brain , 1995, FEBS letters.
[43] A. Yamashita,et al. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. , 1995, Biochemical and biophysical research communications.
[44] Z. Vogel,et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. , 1995, Biochemical pharmacology.
[45] D. Gibson,et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. , 1992, Science.